Akihiko Fukagawa

Akihiko Fukagawa

Auto-generated profile, based on publicly available information

Akihiko Fukagawa

Department of Pathology, Graduate School of Medicine The University of Tokyo Tokyo Japan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2025 in International Journal of Urology
Verified
Journal Article
Closed access
RJRyosuke Jikuya
Ryosuke Jikuya
AFAkihiko Fukagawa
Akihiko Fukagawa
DIDaisuke Ito
Daisuke Ito
HIHiroki Ishihara
Hiroki Ishihara
KTKosuke Takemura
Kosuke Takemura
Fumihiko UrabeFumihiko Urabe
Fumihiko Urabe

20 November 2025 in Cancer Discovery
Verified
Journal Article
Closed access
JTJun Takahashi
Jun Takahashi
YTYosuke Tanaka
Yosuke Tanaka
YSYusuke Sato
Yusuke Sato
HHHisashi Hashimoto
Hisashi Hashimoto
TUToshihide Ueno
Toshihide Ueno
HMHiroyuki Mano
Hiroyuki Mano
Patients with end-stage renal disease (ESRD) are at increased risk of acquired cystic kidney disease (ACKD) and renal tumors, but the molecular basis of such disorders remains elusive. In this study, we performed spatial immunogenomic analyses on 268 specimens from 43 patients with ACKD and associated tumors. The molecular landscape of ESRD-associated tumors is different from that of sporadic renal cell carcinoma. Single-cell and spatial analyses have shown that ACKD is under an inflammatory environment and that the renal cysts in ACKD are derived from proximal tubular cells that have survived the destructive effects of inflammation. Interestingly, we revealed that cysts are formed by clonal expansion and that paracrine activation of the MET tyrosine kinase pathway by the surrounding environment nurtures cysts. Collectively, our results identify the oncogenic mechanisms of ESRD-associated renal tumors and will pave the way for improving the prognosis of patients with ESRD. Significance: We elucidated the molecular basis of renal cancer arising in patients with ESRD and show that the inflammatory environment of ESRD gives rise to field cancerization. See related commentary by Sager et al., p. 426

2 March 2026
Verified
Other
Open access
PDF file
JTJun Takahashi
Jun Takahashi
YTYosuke Tanaka
Yosuke Tanaka
YSYusuke Sato
Yusuke Sato
HHHisashi Hashimoto
Hisashi Hashimoto
TUToshihide Ueno
Toshihide Ueno
HMHiroyuki Mano
Hiroyuki Mano
Supplementary Figure 6: a, Expression patterns of PT-related gene sets in UMAP plots of the integrated scRNA-seq data of the renal cortex of 5 HD patients with ACD-RCC. Supplementary Figure 7: a, Inferred CNV profiles of cyst cells with macrophages used as references. The yellow and green clusters in each figure represent heterogeneous expression clusters of cells within the same cyst. Supplementary Figure 8: a, Expression levels of HGF (macrophage) and MET (cyst) genes in UMAP plots of the integrated scRNA-seq data.

2 March 2026
Verified
Other
Open access
JTJun Takahashi
Jun Takahashi
YTYosuke Tanaka
Yosuke Tanaka
YSYusuke Sato
Yusuke Sato
HHHisashi Hashimoto
Hisashi Hashimoto
TUToshihide Ueno
Toshihide Ueno
HMHiroyuki Mano
Hiroyuki Mano
Patients with end-stage renal disease (ESRD) are at increased risk of acquired cystic kidney disease (ACKD) and renal tumors, but the molecular basis of such disorders remains elusive. In this study, we performed spatial immunogenomic analyses on 268 specimens from 43 patients with ACKD and associated tumors. The molecular landscape of ESRD-associated tumors is different from that of sporadic renal cell carcinoma. Single-cell and spatial analyses have shown that ACKD is under an inflammatory environment and that the renal cysts in ACKD are derived from proximal tubular cells that have survived the destructive effects of inflammation. Interestingly, we revealed that cysts are formed by clonal expansion and that paracrine activation of the MET tyrosine kinase pathway by the surrounding environment nurtures cysts. Collectively, our results identify the oncogenic mechanisms of ESRD-associated renal tumors and will pave the way for improving the prognosis of patients with ESRD.Significance:We elucidated the molecular basis of renal cancer arising in patients with ESRD and show that the inflammatory environment of ESRD gives rise to field cancerization.See related commentary by Sager et al., p. 426

2 March 2026
Verified
Other
Open access
PDF file
JTJun Takahashi
Jun Takahashi
YTYosuke Tanaka
Yosuke Tanaka
YSYusuke Sato
Yusuke Sato
HHHisashi Hashimoto
Hisashi Hashimoto
TUToshihide Ueno
Toshihide Ueno
HMHiroyuki Mano
Hiroyuki Mano
Supplementary Figure 1: a, Frequencies of mutations identified in ACD-RCC (left), ESRD-ccRCC (middle), and sporadicccRCC (right). Supplementary Figure 2: a, UMAP plot of the transcriptomes of tumours from HD patients. Supplementary Figure 3: a, eGFR in the expression-defined cluster groups. The green and pink groups correspond to the groups shown in Figure 3a. Supplementary Figure 4: a, Representative images of each marker via mIHC. Supplementary Figure 5: a, Spatial expression patterns of PT genes and DT genes in the renal cortex of patients not on HD. Scale bar, 2 mm.

9 September 2026 in Pathology International
Verified
Journal Article
Open access
AFAkihiko Fukagawa
Akihiko Fukagawa
NYNao Yoshizawa
Nao Yoshizawa
SIShun Iwai
Shun Iwai
KNKosei Nakamura
Kosei Nakamura
KIKota Itamoto
Kota Itamoto
TYTaichiro Yoshimoto
Taichiro Yoshimoto
Peritoneal lavage cytology (PLC) is important for staging gastric cancer, but intraoperative assessment may miss malignant cells because only a limited portion of the specimen can be examined. We retrospectively analyzed 287 patients who underwent gastrectomy with intraoperative PLC between 2014 and 2022. Cytologic status was classified as CY−, CY0‐to‐CY1 conversion, or CY+ based on intraoperative and permanent cytologic findings. Of 287 patients, 251 were CY−, 10 showed CY0‐to‐CY1 conversion, and 26 were CY+ on intraoperative assessment, resulting in 36 final CY1 cases. Patients with CY0‐to‐CY1 conversion had significantly worse overall survival than CY− patients and outcomes comparable to those of CY+ patients. Serosal invasion/pT4 disease was strongly associated with final CY1 status and was frequent among conversion cases. In a separate technical evaluation, brief ethanol fixation followed by polyethylene glycol and acetone–methanol fixation (Et + PA fixation) significantly improved total cell retention and preservation of tumor‐cell clusters compared with conventional ethanol fixation in 11 paired cases. CY0‐to‐CY1 conversion represents clinically meaningful cytology‐positive disease. Et + PA fixation improves cellular retention during cytologic preparation and may improve the quality of intraoperative PLC preparations.